Patent · US Active

HCV NS4a/modified NS3 polypeptides and uses thereof

US10753939B2 · kind B2 · utility

0Cited by

0References

16Claims

0Family size

Assignees

ORTHO-CLINICAL DIAGNOSTICS, INC. · US
GRIFOLS WORLDWIDE OPERATIONS LIMITED · IE

Inventors

David Chien · Emeryville, US
Doris Coit · Petaluma, US
Toshiya Fujihara · Urayasu, JP
Alexander Gyenes · San Francisco, US
John A. Hall · Abdulrahman Khaleefah Street, US
Angelica Medina-Selby · San Francisco, US
Jian Zheng · Longbeilingcun, CN

Key dates

Filing date	Mar 8, 2019
Grant date	Aug 25, 2020
Priority date	—
Expiry date	Mar 8, 2039

Classification

Technology area (CPC G)Physics
CPC primaryG01N2469/20
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

Modified hepatitis C virus polypeptides are described. The polypeptides include the HCV NS4a domain and modified NS3 domain. The polypeptides retain conformational epitopes. HCV immunoassays including the polypeptides are also described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.